Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study - ScienceDirect
New medicines targeting age-related macular degeneration, Industry news, Media Center, NovaMedica
Endpoints selection in registration clinical trials and the needs of real-world clinical practice with the example of anti-VEGF therapy in neovascular age-related macular degeneration - Astakhov - Ophthalmology Reports
Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData
Age Related Macular Degeneration Market Size, Clinical Trial & Forecast, 2021-2031
Unsuccessful Trials That Investigated Therapies for Age-Related Macular Degeneration | Ophthalmic Surgery, Lasers and Imaging Retina
NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina | National Institutes of Health (NIH)
IJMS | Free Full-Text | Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
Exudative (Wet) Age-Related Macular Degeneration (AMD): Practice Essentials, Background, Pathophysiology
Macular Degeneration AMD | Retina Group of Washington | Wet & Dry AMD MD VA DC
Summary of recent years clinical trials performed for dry age-related... | Download Table
Clinical Trials - Opthea
Macular Degeneration Breakthroughs: Emerging Treatments, New Research
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci
Emerging therapies and their delivery for treating age‐related macular degeneration - Thomas - 2022 - British Journal of Pharmacology - Wiley Online Library
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci